Fig. 4From: Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapyExternal validation and exploration in ACRG cohort. The age-stratified overall survival curve in stage II GC patients (A), and chemotherapy-stratified overall survival curve (B), molecular subtypes (C), and EBV status (D) of new-defined stage II EGC patients in ACRG cohortsBack to article page